Adjusting to Changes in Policy at HHS in 2026 and Beyond

Major clinical trial–related policy changes at the U.S. Department of Health and Human Services (HHS) are leading to ambiguity for sites, sponsors, and contract research organizations. Questions remain on how clinical research professionals can best operationalize these changes, align processes, and address compliance challenges.

A Visit with Mo Ali, the 2026 ACRP Board of Trustees Chair

As experienced pharmaceutical industry executive Mo Ali settled into his volunteer duties as Chair of the ACRP Board of Trustees for 2026, a year in which the Association celebrates its 50th anniversary of service to its members and stakeholders, he took time to answer some questions about his experience in the clinical research enterprise, some of the challenges and opportunities facing it, and how ACRP can further its mission in a time of rapidly evolving technologies and processes.